Follow the JW생명과학 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, JW생명과학 has published 1 reports. Market capitalisation: €170.9bn. The latest transaction was disclosed on 7 April 2026 (Purchase). Among the most active insiders: FILLIMITED. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
JW생명과학 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.